Crossmark

Chronic Viral Hepatitis in Elite Athletes: Approaches to Risk Assessment, Prevention and Management

Published Online: 2022-10-04

Published Print: 2022-12

Authors

Mak, Lung-Yi

Beasley, Ian

Kennedy, Patrick T. F. http://orcid.org/0000-0001-9201-0094
License Information

Text and Data Mining valid from 2022-10-04

Version of Record valid from 2022-10-04
More Information

Article History

Received: 25 April 2022

Accepted: 4 September 2022

First Online: 4 October 2022

Declarations

:

: Not applicable.

: Not applicable.

: Ian Beasley is a director at the International Concussion and Head Injury Foundation, and is Medical Consultant to the Global Performance Unit at City Football Group. Patrick Kennedy has received research grants from Gilead Sciences, received consulting fees from Aligos Therapeutics, Antios Therapeutics, Assembly Biosciences, Gilead Sciences, GlaxoSmithKline, Janssen, Drug Farm and Immunocore, and is the former BASL HBV special interest group lead. Lung-Yi Mak has no competing interests.

Document is current